» Articles » PMID: 34292984

A Mixed-methods Evaluation of the Uptake of Novel Differentiated ART Delivery Models in a National Sample of Health Facilities in Uganda

Overview
Journal PLoS One
Date 2021 Jul 22
PMID 34292984
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Since 2017, Uganda has been implementing five differentiated antiretroviral therapy (ART) delivery models to improve the quality of HIV care and to achieve health-system efficiencies. Community-based models include Community Client-Led ART Delivery and Community Drug Distribution Points. Facility-based models include Fast Track Drug Refill, Facility Based Group and Facility Based Individual Management. We set out to assess the extent of uptake of these ART delivery models and to describe barriers to uptake of either facility-based or community-based models.

Methods: Between December 2019 and February 2020, we conducted a mixed-methods study entailing a cross-sectional health facility survey (n = 116) and in-depth interviews (n = 16) with ART clinic managers in ten case-study facilities as well as six focus group discussions (56 participants) with patients enrolled in differentiated ART models. Facilities were selected based on the 10 geographic sub-regions of Uganda. Statistical analyses were performed in STATA (v13) while qualitative data were analysed by thematic approach.

Results: Most facilities 63 (57%) commenced implementation of differentiated ART delivery in 2018. Fast Track Drug Delivery was the most common facility-based model (implemented in 100 or 86% of health facilities). Community Client-Led ART Delivery was the most popular community model (63/116 or 54%). Community Drug Distribution Points had the lowest uptake with only 33 (24.88%) facilities implementing them. By ownership-type, for-profit facilities reported the lowest uptake of differentiated ART models. Barriers to enrolment in community-based models include HIV-related stigma and low enrolment of adult males in community models.

Conclusion: To the best of our knowledge this is the first study reporting national coverage of differentiated ART delivery models in Uganda. Overall, there has been a higher uptake of facility-based models. Interventions for enhancing the uptake of differentiated ART models in for-profit facilities are recommended.

Citing Articles

Impact of Differentiated Service Delivery Models on Quality of Life among People living with HIV in Uganda - A Quasi-Experimental Study.

Nasasira B, Banturaki G, Kalema N, Musaazi J, Nanvuma A, Okoboi S Res Sq. 2025; .

PMID: 39764111 PMC: 11702836. DOI: 10.21203/rs.3.rs-5443965/v1.


Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries.

Lalla-Edward S, Venter W Curr HIV/AIDS Rep. 2024; 22(1):2.

PMID: 39548044 PMC: 11568023. DOI: 10.1007/s11904-024-00710-3.


Costs and resource distribution of direct services for HIV in Uganda.

Ekirapa E, Jordan M, Nong T, Marton T, Balidawa H, Ssempala R BMJ Open. 2024; 14(10):e082062.

PMID: 39384227 PMC: 11474907. DOI: 10.1136/bmjopen-2023-082062.


Evaluating Antiretroviral Therapy Service Delivery Models Through Lot Quality Assurance Sampling in Central Uganda.

Mukama S, Nakawesi J, Bindeeba D, Ezajobo S, Mugisa A, Senyimba C HIV AIDS (Auckl). 2024; 16:337-354.

PMID: 39258105 PMC: 11385700. DOI: 10.2147/HIV.S475258.


Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda.

Zakumumpa H, Alinaitwe A, Kyomuhendo M, Nakazibwe B BMC Infect Dis. 2024; 24(1):876.

PMID: 39198739 PMC: 11360315. DOI: 10.1186/s12879-024-09748-5.


References
1.
Wilkinson L, Grimsrud A . The time is now: expedited HIV differentiated service delivery during the COVID-19 pandemic. J Int AIDS Soc. 2020; 23(5):e25503. PMC: 7203569. DOI: 10.1002/jia2.25503. View

2.
Duncombe C, Rosenblum S, Hellmann N, Holmes C, Wilkinson L, Biot M . Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health. 2015; 20(4):430-47. PMC: 4670701. DOI: 10.1111/tmi.12460. View

3.
Yotebieng M, Brazier E, Addison D, Kimmel A, Cornell M, Keiser O . Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019; 22(1):e25218. PMC: 6338103. DOI: 10.1002/jia2.25218. View

4.
Zakumumpa H, Bennett S, Ssengooba F . Accounting for variations in ART program sustainability outcomes in health facilities in Uganda: a comparative case study analysis. BMC Health Serv Res. 2016; 16(1):584. PMC: 5070310. DOI: 10.1186/s12913-016-1833-4. View

5.
Sengupta S, Banks B, Jonas D, Miles M, Smith G . HIV interventions to reduce HIV/AIDS stigma: a systematic review. AIDS Behav. 2010; 15(6):1075-87. PMC: 3128169. DOI: 10.1007/s10461-010-9847-0. View